Search - tctmd.com

Displaying 381 - 400 of 1026

Sort: Relevancy | Date

News Daily News

FDA Issues New Guidance on Sodium Targets for Food Industry

L.A. McKeown

October 14, 2021

Antithrombotic therapy does not provide a benefit for clinically stable but symptomatic outpatients with COVID-19, published results of the ACTIV-4b trial affirm. Neither aspirin nor apixaban (Eliquis; Bristol Myers Squibb) at prophylactic or therapeutic doses reduced what were already very low rates of major adverse cardiopulmonary outcomes versus placebo, and both modestly increased bleeding, researchers led by Jean Connors, MD (Brigham and Women’s Hospital, Boston, MA), report in a paper published online

News Daily News

ACTIV-4b: No Antithrombotic Therapy Needed for COVID-19 Outpatients

Todd Neale

October 13, 2021

News Daily News

HEP-COVID: Therapeutic-Dose Heparin Effective in Non-ICU Patients

Yael L. Maxwell

October 12, 2021

News Daily News

Rivaroxaban Again Linked to More Bleeding vs Other DOACs

Caitlin E. Cox

October 11, 2021

News Daily News

Higher Dose vs Added Antihypertensive? Older Patients Face Trade-offs

Yael L. Maxwell

October 07, 2021

News Daily News

Diabetes Progression in Statin-Treated Patients: VA Data

Michael O'Riordan

October 06, 2021

News Daily News

Post-ACS Patients With Low LDL Levels Remain at Risk: IMPROVE-IT

Michael O'Riordan

October 04, 2021

News Daily News

Infective Endocarditis Rare After AVR, but Often a Killer When It Occurs

Michael O'Riordan

October 01, 2021

News Daily News

Vasopressor/Steroid Combo Jump-starts Circulation for In-Hospital Cardiac Arrests

Caitlin E. Cox

September 30, 2021

News Daily News

High Burden of CAD in Chest Pain Patients With ‘Normal’ Troponin

Michael O'Riordan

September 27, 2021

News Daily News

AHA Stresses Benefit of Meds, Surgery for Obesity-Related Hypertension

Yael L. Maxwell

September 23, 2021

News Daily News

Cumulative Burden of LDL Cholesterol Increases CHD Risk

Michael O'Riordan

September 23, 2021

News Daily News

Early Menopause Linked to Increased ASCVD Risk

L.A. McKeown

September 17, 2021

News Daily News HFSA 2021

In HF and Diabetes, Mobile Health App Modestly Boosts Physical Activity

Michael O'Riordan

September 15, 2021

News Daily News

Heterozygous FH Diagnosed Late, Remains Undertreated

Michael O'Riordan

September 13, 2021

News Daily News

Switching to Tenecteplase for Stroke Thrombolysis May Boost Outcomes

Todd Neale

September 09, 2021

News Daily News

Could an App Replace Statin Prescribing by Doctors?

Michael O'Riordan

September 08, 2021

News Daily News

Biomarker Levels ID Patients With Most to Gain From Intensive BP Lowering

Todd Neale

September 08, 2021

News Daily News

As CDC Moves to Update Contraception Guidance, Cardiologists Should Take Note

Alexandra Dangas

September 06, 2021

News Daily News

Colchicine Lowers CVD Risk No Matter When Past ACS Occurred: LoDoCo2

Michael O'Riordan

August 26, 2021

Advertisement

FDA Issues New Guidance on Sodium Targets for Food Industry

ACTIV-4b: No Antithrombotic Therapy Needed for COVID-19 Outpatients

HEP-COVID: Therapeutic-Dose Heparin Effective in Non-ICU Patients

Rivaroxaban Again Linked to More Bleeding vs Other DOACs

Higher Dose vs Added Antihypertensive? Older Patients Face Trade-offs

Diabetes Progression in Statin-Treated Patients: VA Data

Post-ACS Patients With Low LDL Levels Remain at Risk: IMPROVE-IT

Infective Endocarditis Rare After AVR, but Often a Killer When It Occurs

Vasopressor/Steroid Combo Jump-starts Circulation for In-Hospital Cardiac Arrests

High Burden of CAD in Chest Pain Patients With ‘Normal’ Troponin

AHA Stresses Benefit of Meds, Surgery for Obesity-Related Hypertension

Cumulative Burden of LDL Cholesterol Increases CHD Risk

Early Menopause Linked to Increased ASCVD Risk

In HF and Diabetes, Mobile Health App Modestly Boosts Physical Activity

Heterozygous FH Diagnosed Late, Remains Undertreated

Switching to Tenecteplase for Stroke Thrombolysis May Boost Outcomes

Could an App Replace Statin Prescribing by Doctors?

Biomarker Levels ID Patients With Most to Gain From Intensive BP Lowering

As CDC Moves to Update Contraception Guidance, Cardiologists Should Take Note

Colchicine Lowers CVD Risk No Matter When Past ACS Occurred: LoDoCo2

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content